KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Change in Accured Expenses (2016 - 2025)

National Health Investors (NHI) has disclosed Change in Accured Expenses for 17 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 19.34% year-over-year to $8.1 million, compared with a TTM value of $5.5 million through Dec 2025, up 67.12%, and an annual FY2025 reading of $5.5 million, up 67.12% over the prior year.
  • Change in Accured Expenses was $8.1 million for Q4 2025 at National Health Investors, up from $1.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $8.1 million in Q4 2025 and bottomed at -$8.5 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $924050.0, with a median of $1.3 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses soared 366.12% in 2022, then tumbled 508.13% in 2024.
  • Year by year, Change in Accured Expenses stood at $5.9 million in 2021, then tumbled by 49.86% to $3.0 million in 2022, then surged by 54.77% to $4.6 million in 2023, then soared by 46.75% to $6.8 million in 2024, then rose by 19.34% to $8.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for NHI at $8.1 million in Q4 2025, $1.8 million in Q3 2025, and $4.1 million in Q2 2025.